3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
8
Multiple Myeloma
4
Glioma
4
Thyroid Neoplasms
2
Neoplasms
2
Neoplasm Metastasis
2
Lymphoma
2
Lung Neoplasms
2
Hematologic Neoplasms
2
Glioblastoma
2
Colorectal Neoplasms
2
Astrocytoma
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Stomach Neoplasms
1
Spinocerebellar Degenerations
1
Sarcoma
1
Refractory Differentiated Thyroid Gland Carcinoma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Oligodendroglioma
1
Neurofibromatosis 1
1
Neurofibroma, Plexiform
1
Neurocytoma
1
Neuroblastoma
1
Metastatic Radioactive Iodine Refractory Thyroid Cancer Patients With RAS or BRAF Mutation
1
Interventions
Magnetic Resonance Spectroscopy
3
Specimen Handling
2
Interviews as Topic
2
tremelimumab
1
trametinib
1
omipalisib
1
gallium Ga 68 dotatate
1
durvalumab
1
cabozantinib
1
X-Rays
1
Sodium Iodide
1
Phantoms, Imaging
1
Nivolumab
1
Ipilimumab
1
Iodine-131
1
Iodine-124
1
Counseling
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma, Follicular
×
dabrafenib
×
90 days
×
Clear all
No trials found.